Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Gyorgy Rokszin"'
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Externí odkaz:
https://doaj.org/article/7ea3a430a7854d158216f0fc7e1015cd
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Purpose: This study aimed to provide real-world evidence on the characteristics, treatment patterns, and outcomes of patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitor (TKI) treatment in Hungary between 2011 and 2019.Pat
Externí odkaz:
https://doaj.org/article/0a06df27294a420cacee361560287976
Autor:
Miklos Kasler, Gábor Sütő, Gergő A Molnár, Gyorgy Rokszin, Zoltan Kiss, István Wittmann, István Kenessey, Zoltan Voko, Andras Weber, Peter Nagy, Dávid Nagy, György Surján, Orsolya Surján, Mihály Pálosi, Cecília Müller
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 1 (2024)
Introduction Type 2 diabetes mellitus is a risk factor for severe COVID-19 infection and is associated with increased risk of complications. The present study aimed to investigate effectiveness and persistence of different COVID vaccines in persons w
Externí odkaz:
https://doaj.org/article/b64af17cd3764933b7c04f76d2b35071
Autor:
Gyula Poór, Gábor Sütő, Gergő A Molnár, Gyorgy Rokszin, Ibolya Fábián, Zoltan Kiss, György Jermendy, Peter Kempler, István Wittmann
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Mortality and disability in diabetes mellitus are determined mostly by cardiovascular complications and cancer. The impact of dipeptidyl peptidase-4 inhibitor (DPP-4i) and sodium-glucose cotransporter-2 inhibitor (SGLT2i) monotherapy or
Externí odkaz:
https://doaj.org/article/e0b7b53cbea94d9b9fd36a0ad12d42b2
Autor:
Tímea Papp, György Rokszin, Zoltán Kiss, Dávid Becker, Béla Merkely, Zoltán Járai, András Jánosi, Zoltán Csanádi
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 3, Pp 615-630 (2024)
Abstract Introduction Atrial fibrillation (AF) and heart failure (HF) often coexist due to the common elements of the pathomechanism they share. The potential significance of the order these entities present in the same patient is ill-defined. Herein
Externí odkaz:
https://doaj.org/article/49abe426dc194af8862255597e0bb37c
Autor:
Zoltán Kiss, Tamás G. Szabó, Csaba Polgár, Zsolt Horváth, Péter Nagy, Ibolya Fábián, Valéria Kovács, György Surján, Zsófia Barcza, István Kenessey, András Wéber, István Wittmann, Gergő Attila Molnár, Eszter Gyöngyösi, Angéla Benedek, Eugenia Karamousouli, Zsolt Abonyi-Tóth, Renáta Bertókné Tamás, Diána Viktória Fürtős, Krisztina Bogos, Judit Moldvay, Gabriella Gálffy, Lilla Tamási, Veronika Müller, Zoárd Tibor Krasznai, Gyula Ostoros, Zsolt Pápai-Székely, Anikó Maráz, Gabriella Branyiczkiné Géczy, Lászlóné Hilbert, Láśzló Tamás Berki, György Rokszin, Zoltán Vokó
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe nationwide HUN-CANCER EPI study examined cancer incidence and mortality rates in Hungary from 2011 to 2019.MethodsUsing data from the National Health Insurance Fund (NHIF) and Hungarian Central Statistical Office (HCSO), our retrospecti
Externí odkaz:
https://doaj.org/article/03adbbbd3d054b19a967d6a6c292c818
Autor:
Gabriella Gálffy, Géza Tamás Szabó, Lilla Tamási, Veronika Müller, Judit Moldvay, Veronika Sárosi, Anna Kerpel-Fronius, Tamás Kardos, Edit Csada, Zsolt Pápai-Székely, Zoltán Szász, Zsolt Király, Gábor Hódi, Zsuzsanna Kovács, Éva Balogh, Krisztina Andrea Kovács, Miklós Darida, Viktória Buga, György Rokszin, Zsolt Abonyi-Tóth, Zoltán Kiss, Zoltán Vokó, Krisztina Bogos
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
ObjectiveHungary has repeatedly been shown to have the highest cancer-related mortality and incidence in Europe. Despite lung cancer being the most abundant malignant diagnosis in Hungary, numerous concerns have been raised recently regarding the bia
Externí odkaz:
https://doaj.org/article/9bde8f083408482c872f58d4f50c4120
Autor:
Zoltán Kiss, Gabriella Gálffy, Veronika Müller, Judit Moldvay, Veronika Sárosi, Zsolt Pápai-Székely, Edit Csada, Anna Kerpel-Fronius, Zsolt Király, Zoltán Szász, Gábor Hódi, Zoltán Polányi, Krisztina Kovács, Eugenia Karamousouli, Kata Knollmajer, Tamás G. Szabó, Andrea Berta, Zoltán Vokó, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, Lilla Tamási, Krisztina Bogos
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19
Externí odkaz:
https://doaj.org/article/af41d80cfb264262bce0e68d6b8a2c77
Autor:
Zoltán Kiss, Judit Kocsis, Alíz Nikolényi, Zsolt Horváth, Kata Knollmajer, Angéla Benedek, Máté Várnai, Zoltán Polányi, Krisztina Andrea Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, Tamás Géza Szabó, György Rokszin, Ibolya Fábián, Renáta Bartókné Tamás, Orsolya Surján, Diána Fürtős, György Surján, István Kenessey, András Weber, Zsófia Barcza, Tamás Berki, Zoltán Vokó, Csaba Dózsa, Magdolna Dank, Katalin Boér
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThis nationwide study examined breast cancer (BC) incidence and mortality rates in Hungary between 2011–2019, and the impact of the Covid-19 pandemic on the incidence and mortality rates in 2020 using the databases of the National Health
Externí odkaz:
https://doaj.org/article/563725034a014ce581808178c17b517d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.